Vitamin D and Endometrial Receptivity in Infertile Women (NCT04721899) | Clinical Trial Compass
RecruitingNot Applicable
Vitamin D and Endometrial Receptivity in Infertile Women
Hong Kong105 participantsStarted 2021-01-15
Plain-language summary
This is a prospective study comparing vaginal and endometrial biomarkers and the trophoblast spheroid attachment rate in women with fertility problems before and after taking Vitamin D for 8 weeks.
Who can participate
Age range18 Years – 40 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age of women \< 40years old
* Normal uterine cavity as demonstrated by pelvic scanning with or without saline infusion sonogram or hysteroscopy
* Regular ovulatory cycles
They will be divided into three groups:
* RIF patients (n=35)- those who have failed to get pregnant after replacing four or more cleavage stage embryos or two or more blastocysts in two consecutive transfers.
* RPL patients (n=35)- those who have failed in three pregnancies before 24 weeks of gestation and includes embryonic and fetal losses.
* 'Infertile group'(n=35)- infertility except RIF and RPL, e.g. those seeking for preimplantation genetic testing, male factor infertility, unexplained infertility.
Exclusion Criteria:
* History of any medical condition or medications that may predispose to vitamin D sensitivity, altered vitamin D metabolism and/ or hypercalcemia, including active tuberculosis or current therapy for tuberculosis, sarcoidosis, history of renal/ ureteral stones, parathyroid disease, renal or liver failure or current use of anti-convulsants
* Taking vitamin D supplement
* Endometrial polyp or fibroid distorting the uterine cavity
* Presence of hydrosalpinx not corrected surgically
* Refusal to join the study
• Discontinuation criteria-
* If the woman becomes pregnant during the study
* Pelvic inflammatory disease/ uterine perforation after endometrial biopsy
* Vitamin D toxicity (hypercalcemia)
* Withdrawal by patient